Malaysia's medicine supply remains stable until June, despite rising costs, according to Health Minister Datuk Seri Dzulkefly Ahmad. This stability is attributed to combined government and industry stockpiles, ensuring a sufficient supply of essential medicines like insulin and vaccines. However, the minister acknowledges the impact of global economic factors on medicine and medical device costs, with prices rising by 30-40% for medicines and 50-100% for some medical devices. Supply chain disruptions, including delays in medical device shipments, have further exacerbated these price increases. The Ministry of Health (MOH) is actively addressing these challenges by collaborating with the Ministry of Finance, Ministry of Economy, and Ministry of Domestic Trade and Cost of Living to implement solutions. These discussions include a cost pass-through mechanism and appropriate rates to manage the issue without affecting healthcare services. Minister Dzulkefly reassures the public that the government is in control and will take stricter measures to prevent supply disruptions, emphasizing the importance of maintaining a stable and controlled healthcare system.
